Antisense modulation of P38 mitogen activated protein kinase expression |
| OF THE INVENTION p38 MAPKs play an important role in signal transduction in response to cytokines, ... |
|
Antisense modulation of CD44 expression |
| OF THE INVENTION The present invention employs oligomeric antisense compounds, particularly ... |
|
Antisense modulation of Smad7 expression |
| OF THE INVENTION The present invention employs oligomeric antisense compounds, particularly ... |
|
Antisense modulation of nucleolin expression |
| OF THE INVENTION The present invention employs oligomeric antisense compounds, particularly ... |
|
Antisense modulation of hnRNP A1 expression |
| OF THE INVENTION The present invention employs oligomeric antisense compounds, particularly ... |
|
Antisense inhibition of E2F transcription factor 3 expression |
| OF THE INVENTION The present invention employs oligomeric antisense compounds, particularly ... |
|
Antisense inhibition of rank expression |
| OF THE INVENTION The present invention employs oligomeric antisense compounds, particularly ... |
|
Antisense inhibition of protein kinase C-theta expression |
| OF THE INVENTION The present invention employs oligomeric antisense compounds, particularly ... |
|
Antisense oligonucleotide modulation of human mdm2 expression |
| OF THE INVENTION Tumors often result from genetic changes in cellular regulatory genes. Among the ... |
|
|
Solid phase diagnosis of medical conditions
| Details |
Inventors: Uhlen, Mathias;
Assignee: CEMU Bitecknik AB (Uppsala, SE)
Primary Examiner: Zitomer; Stephanie W.
Assistant Examiner:
Attorney, Agent or Firm: Foley & Lardner
A method of and kit for diagnosis of medical conditions by identification of specific DNA characterized in that DNA in a sample is subjected to initial amplification by the polymerase chain reaction (PCR) method using a first pair of primers specific to the target DNA and the amplified DNA so produced is further amplified by the PCR method using a second primer pair, one or both of which are different from either of said first primer pair and are specific to a sequence or sequences of the target DNA between the hybridization sites of said first primer pair, one of the primers of said second primer pair being immobilized on a solid support or being provided with means for subsequent attachment to a solid support and the other of said second pair of primers carrying a label or being provided with means for subsequent attachment to a label, said amplification being followed by separation of said solid support carrying said amplified DNA and detection of label attached thereto, one or both of said means for subsequent attachment comprising a distal DNA sequence carried by the said primer which does not hybridize with the target DNA but has a selective affinity for a binding partner attached to either a solid support or a label. |
|
DETAILED DESCRIPTION I claim: 1. A method for detecting a target polynucleotide that is characteristic of a pathological condition, comprising the steps of: (a) producing a first amplified DNA by a first polymerass chain reaction using a first set of primers to amplify a target polynucleotide characteristic of a pathological condition; (b) producing from said first amplified DNA a second amplified DNA by a second polymerass chain reaction using a second set of primers, wherein: (i) said second primers differ from said first primers, (ii) a 5' region of said second primers is not complementary to said first amplified DNA, (iii) one of said second primers is biotinylated, and (iv) another of said second primers comprises means for binding a detectable label; (c) binding said biotinylated second primer to a solid support before, during or after said second polymerase chain reaction, whereby said second amplified DNA is bound to said support; (d) binding a detectable label to said means for binding a detectable label after said second polymerase chain reaction, whereby said detectable label is bound to said second amplified DNA, wherein said second amplified DNA is double-stranded; and (e) detecting said target polynucleotide by determining the detectable label bound to said double-stranded second amplified DNA. 2. A kit for detecting a target polynucleotide that is characteristic of a pathological condition, said target polynucleotide being first amplified by a first polymerase chain reaction using first primers, said kit comprising a set of second primers for producing a second amplified DNA from said first amplified DNA, wherein: (i) said second primers differ from said first primers, (ii) a 5' region of said second primers is not complementary to said first amplified DNA, (iii) one of said second primers is biotinylated, and (iv) another of said second primers comprises means for binding a detectable label, said biotinylated second primer being effective, before, during or after said second amplification reaction, to immobilize said second amplified DNA on a solid support comprising a biotin-binding moiety, and said means for binding a detectable label being effective, after said amplification reaction, to bind a label to said second amplified DNA, wherein said second amplified DNA is double-stranded, whereby said target polynucleotide may be detected by determining said label bound to said double-stranded second amplified DNA
|
| Related patents |
|
|
Use of microparticles combined with submicron oil-in-water emulsions
OF THE INVENTION The practice of the present invention will employ, unless otherwise indicated, conventional methods of chemistry, biochemistry, molecular biology, ...
|
|
|
Methods of treating hypertension and compositions for use therein
The present invention provides methods of treating hypertension, particularly essential hypertension. The methods generally involve providing a stimulator of ...
|
|
|
Use of microparticles combined with submicron oil-in-water emulsions
OF THE INVENTION The practice of the present invention will employ, unless otherwise indicated, conventional methods of chemistry, biochemistry, molecular biology, ...
|
|
|
6,11-bicyclic erythromycin derivatives
OF THE INVENTION A first embodiment of the present invention is a compound of formula I as defined herein, or its pharmaceutically acceptable salt, ester, or prodrug. R...
|
|
|
Method of producing infectious reovirus
OF THE INVENTION The present invention is directed to a method of producing mammalian reovirus by using human embryo kidney 293 (HEK 293) cells. We found that HEK 293 ...
|
|
|
CDNA sequences of human bone matrix proteins
It is, therefore, an object of the present invention to provide specific cDNA and deduced protein sequences which are diagnostic of such human diseases as osteoporosis, ...
|
|
|
Antisense inhibition of PEPCK-mitochondrial expression
OF THE INVENTION The present invention employs oligomeric antisense compounds, particularly oligonucleotides, for use in modulating the function of nucleic acid ...
|
|
|
Methods of modulating tumor necrosis factor .alpha.-induced expression of cell adhesion molecules
OF THE INVENTION The present invention employs specific inhibitors of Ha-ras, c-raf and JNK2, members of the TNF-.alpha. signaling pathway, to modulate cell adhesion ...
|
|
|
Antisense modulation of telomeric repeat binding factor 1 expression
OF THE INVENTION The present invention employs oligomeric antisense compounds, particularly oligonucleotides, for use in modulating the function of nucleic acid ...
|
|
|
Antisense modulation of interleukin-5 signal transduction
OF THE INVENTION The present invention comprehends antisense compounds capable of modulating IL-5 signal transduction, preferably by modulating expression of IL-5 or IL-...
|
|
|